Pfizer Boosts Anti-infectives Pipeline with Amplyx Pharmaceuticals Acquisition
Pfizer announced on Wednesday, the acquisition of Amplyx Pharmaceuticals, Inc., a privately-owned company focused on the engineering of treatments for
Read morePfizer announced on Wednesday, the acquisition of Amplyx Pharmaceuticals, Inc., a privately-owned company focused on the engineering of treatments for
Read moreThermo Fisher Scientific, a global leader in serving science, introduced the Helios 5 EXL Wafer DualBeam, which is engineered to
Read moreBristol-Myers Squibb is investing in a brand new cell therapy facility which will be located at the Leiden Bio Science
Read morePhico Therapeutics (‘Phico’), a British biotech company developing engineered phage technologies as the foundation of a new wave of antibiotics
Read moreGSK and Vir Biotechnology have announced that the EMA has started a review of the dual-action monoclonal Antibody VIR-7831 for
Read moreEvotec SE, a publicly listed drug discovery and development company headquartered in Hamburg, Germany, has launched beLAB2122, a translational $
Read moreSanofi revealed on April 12, 2021, that it will spend €400 million over five years in Singapore to build a
Read moreExscientia, a leading artificial intelligence (AI) driven pharmatech company based in Oxford, England, announced that the first AI-designed molecule for
Read moreTeva Pharmaceuticals Europe reported that Seffalair Spiromax and its duplicate BroPair Spiromax (salmeterol xinafoate/fluticasone propionate, 12.75/100 and 12.75/202 micrograms administered
Read moreThe Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Panacea Biotec, India’s largest vaccine and pharmaceutical manufacturer, have
Read more